GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (NSE:BLISSGVS) » Definitions » Days Sales Outstanding

Bliss GVS Pharma (NSE:BLISSGVS) Days Sales Outstanding : 186.23 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Bliss GVS Pharma Days Sales Outstanding?

Bliss GVS Pharma's average Accounts Receivable for the three months ended in Mar. 2024 was ₹4,043 Mil. Bliss GVS Pharma's Revenue for the three months ended in Mar. 2024 was ₹1,981 Mil. Hence, Bliss GVS Pharma's Days Sales Outstanding for the three months ended in Mar. 2024 was 186.23.

The historical rank and industry rank for Bliss GVS Pharma's Days Sales Outstanding or its related term are showing as below:

NSE:BLISSGVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 156.31   Med: 209.58   Max: 324.68
Current: 184.43

During the past 13 years, Bliss GVS Pharma's highest Days Sales Outstanding was 324.68. The lowest was 156.31. And the median was 209.58.

NSE:BLISSGVS's Days Sales Outstanding is ranked worse than
93.48% of 997 companies
in the Drug Manufacturers industry
Industry Median: 71.44 vs NSE:BLISSGVS: 184.43

Bliss GVS Pharma's Days Sales Outstanding declined from Mar. 2023 (190.21) to Mar. 2024 (186.23).


Bliss GVS Pharma Days Sales Outstanding Historical Data

The historical data trend for Bliss GVS Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma Days Sales Outstanding Chart

Bliss GVS Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 269.94 324.68 211.84 188.89 187.07

Bliss GVS Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 190.21 220.32 162.82 171.87 186.23

Competitive Comparison of Bliss GVS Pharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Bliss GVS Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bliss GVS Pharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bliss GVS Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bliss GVS Pharma's Days Sales Outstanding falls into.



Bliss GVS Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bliss GVS Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (3851.659 + 4043.467) / 2 ) / 7702.449*365
=3947.563 / 7702.449*365
=187.07

Bliss GVS Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0 + 4043.467) / 1 ) / 1981.283*365 / 4
=4043.467 / 1981.283*365 / 4
=186.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bliss GVS Pharma  (NSE:BLISSGVS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Bliss GVS Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Bliss GVS Pharma (NSE:BLISSGVS) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400 072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Geographically, it derives a majority of revenue from Outside India. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.

Bliss GVS Pharma (NSE:BLISSGVS) Headlines

No Headlines